- Home
- SCTX vs MAX Comparison
SCTX vs MAX Comparison
Compare SCTX & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCTX | MAX |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.5M | 491.1M |
| IPO Year | 2026 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SCTX | MAX |
|---|---|---|
| Price | $17.20 | $9.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $57.00 | $15.43 |
| AVG Volume (30 Days) | 271.3K | ★ 676.7K |
| Earning Date | 09-02-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.81 |
| EPS | N/A | ★ 0.86 |
| Revenue | N/A | ★ $1,113,600,000.00 |
| Revenue This Year | N/A | $17.31 |
| Revenue Next Year | N/A | $8.70 |
| P/E Ratio | ★ N/A | $10.92 |
| Revenue Growth | N/A | ★ 28.78 |
| 52 Week Low | $17.31 | $7.09 |
| 52 Week High | $39.60 | $14.70 |
Technical Indicators
Market Signals| Indicator | SCTX | MAX |
|---|---|---|
| Relative Strength Index (RSI) | 34.53 | 33.64 |
| Support Level | N/A | $9.41 |
| Resistance Level | $26.50 | $10.26 |
| Average True Range (ATR) | 3.71 | 0.55 |
| MACD | -1.36 | -0.06 |
| Stochastic Oscillator | 4.94 | 23.19 |
Price Performance
Historical ComparisonAbout SCTX Scribe Therapeutics Inc. Common Stock
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
About MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that enables insurance carriers and distributors to target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It serves as a customer acquisition channel in property and casualty insurance, health insurance, and life insurance. The company operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.